Sbir phase II: safer batteries to mitigate injuries from accidental ingestion in children

Landsdowne Labs LLC received a $1.0 million Cooperative Agreement from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective October 1, 2025 through September 30, 2027. The awardee will develop and deliver safer battery casing technology designed to passively deactivate coin cell batteries upon exposure to bodily fluids, thereby mitigating serious injuries and fatalities from accidental pediatric ingestion. The deliverables include optimized battery casing compositions utilizing electrochemically responsive metals, scalable fabrication techniques, mechanical integrity assessments, and rigorous electrochemical testing protocols validated under simulated ingestion conditions.

The innovation addresses a significant public health challenge, with over 70,000 battery-related emergency room visits recorded in the United States between 2010 and 2019. By incorporating a passive safety mechanism requiring no external electronics or internal design modifications, the technology enables battery manufacturers to adopt enhanced safety standards with minimal production disruption. The research further advances understanding of environmentally responsive materials and has potential applications beyond consumer protection, including integration into battery-powered ingestible and implantable medical devices, thereby extending the commercial and societal impact across the broader medical device sector.

Abstract

The broader/commercial impact of this small business innovation research (sbir) phase II project is to reduce the serious and sometimes fatal injuries caused by accidental ingestion of coin cell batteries, particularly in children. From 2010 to 2019, over 70,000 battery-related emergency room visits were recorded in the united states, with some resulting in internal burns, surgeries, or death. This project aims to develop safer battery casings that passively deactivate upon exposure to bodily fluids, reducing the risk of electrochemical injury. By providing a built-in safety mechanism that requires no external electronics or internal design changes, this innovation enables battery manufacturers to adopt enhanced safety standards with minimal production disruption. In addition to protecting children, the same technology could be extended to battery-powered ingestible and implantable medical devices, offering a broader benefit to public health. The work also advances scientific understanding of environmentally responsive materials and their integration into real-world consumer products. This small business innovation research (sbir) phase II project focuses on addressing the technical challenge of preventing current-induced tissue damage when coin cell batteries contact wet environments. The innovation lies in the use of metals that exhibit distinct electrochemical properties depending on environmental conductive fluids. The research will optimize the composition, thickness, and surface treatment of battery casings made from these materials to ensure that they suppress current when wet while maintaining dry- and humid-state performance and durability. The project includes development of scalable fabrication techniques, evaluation of mechanical integrity, and rigorous electrochemical testing under simulated ingestion conditions. A critical component of the research is maintaining the battery's internal seal to prevent moisture ingress while enabling the passive safety mechanism. Successful outcomes will lead to a manufacturable, safety-enhanced coin cell battery design with applications in consumer electronics and medical technologies. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.- subawards are not planned for this award.